REPLY: Increased Mortality by Digoxin in Patients With Atrial Fibrillation?

被引：0
|
作者：
Turakhia, Mintu P. [1 ]
Heidenreich, Paul A. [1 ]
机构：
[1] Stanford Univ, Sch Med, Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 02期
关键词：
AFFIRM TRIAL;
D O I：
10.1016/j.jacc.2014.10.032
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：221 / 221
页数：1
相关论文
共 50 条
  • [31] Atrial Fibrillation Is Associated with Increased Mortality in Patients Presenting with Ventricular Tachyarrhythmias
    Behnes, Michael
    Rusnak, Jonas
    Taton, Gabriel
    Schupp, Tobias
    Reiser, Linda
    Bollow, Armin
    Reichelt, Thomas
    Engelke, Niko
    Ellguth, Dominik
    Kuche, Philipp
    El-Battrawy, Ibrahim
    Lang, Siegfried
    Nienaber, Christoph A.
    Mashayekhi, Kambis
    Akin, Muharrem
    Bertsch, Thomas
    Ferdinand, Dennis
    Weiss, Christel
    Borggrefe, Martin
    Akin, Ibrahim
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [32] Atrial Fibrillation Is Associated with Increased Mortality in Patients Presenting with Ventricular Tachyarrhythmias
    Michael Behnes
    Jonas Rusnak
    Gabriel Taton
    Tobias Schupp
    Linda Reiser
    Armin Bollow
    Thomas Reichelt
    Niko Engelke
    Dominik Ellguth
    Philipp Kuche
    Siegfried Ibrahim El-Battrawy
    Christoph A. Lang
    Kambis Nienaber
    Muharrem Mashayekhi
    Thomas Akin
    Dennis Bertsch
    Christel Ferdinand
    Martin Weiss
    Ibrahim Borggrefe
    Scientific Reports, 9
  • [33] The association of atrial fibrillation with mortality in patients with breast cancer: author reply
    Guha, Avirup
    Alonso, Alvaro
    Addison, Daniel
    EUROPEAN HEART JOURNAL, 2022, 43 (12) : 1269 - 1270
  • [34] Atrial Fibrillation - A Risk Factor for increased Mortality
    不详
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2019, 114 (05) : 398 - 399
  • [35] Digoxin Is Associated With Increased All-cause Mortality in Patients With Atrial Fibrillation Regardless of Concomitant Heart Failure: A Meta-analysis
    Wang, Zhi-Quan
    Zhang, Rui
    Chen, Man-Tian
    Wang, Qun-Shan
    Zhang, Yi
    Huang, Xiao-Hong
    Wang, Jun
    Yan, Jian-Hua
    Li, Yi-Gang
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 66 (03) : 270 - 275
  • [36] Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation
    Chirinos, JA
    Castrellon, A
    Zambrano, JP
    Jimenez, JJ
    Jy, W
    Horstman, LL
    Willens, HJ
    Castellanos, A
    Myerburg, RJ
    Ahn, YS
    HEART RHYTHM, 2005, 2 (05) : 525 - 529
  • [37] DIGOXIN USE IS ASSOCIATED WITH A HIGHER RISK OF ALL-CAUSE MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION
    Shah, M.
    Tsadok, M. Avgil
    Essebag, V.
    Jackevicius, C. A.
    Eisenberg, M. J.
    Pilote, L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S105 - S105
  • [38] The DIGAF study (Digoxin in atrial fibrillation): Cardioversion of atrial fibrillation with high dose digoxin
    Stuehlinger, HG
    Domanovits, H
    Gamper, G
    Stix, G
    Zeiner, A
    Woisetschlaeger, C
    Laggner, AN
    CIRCULATION, 1997, 96 (08) : 2537 - 2537
  • [39] COMPARISON OF MEDIGOXIN AND DIGOXIN IN PATIENTS WITH ATRIAL-FIBRILLATION
    KONGOLA, GWM
    COBURN, PR
    MAWER, GE
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (06) : P727 - P727
  • [40] Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation
    Zeng, Wu-Tao
    Liu, Zhi-Hao
    Li, Zhu-Yu
    Zhang, Ming
    Cheng, Yun-Jiu
    MEDICINE, 2016, 95 (12)
12345